U.S. Retail REITs Stock News

NYSE:GWRE
NYSE:GWRESoftware

Guidewire (GWRE) Stock Looks Like A Bargain On Cash Flow But Rich On Earnings

Guidewire Software's valuation is pulling in two directions right now, with the Discounted Cash Flow (DCF) intrinsic value estimate suggesting the stock trades at a 32.4% discount, while market multiples make it look expensive on more traditional pricing metrics. Over the past 3 years, Guidewire Software has returned 76.0%, which puts the recent share price in the context of a longer period of solid investor gains. Recent earnings news has supported expectations for further revenue growth,...
NYSE:SSTK
NYSE:SSTKInteractive Media and Services

Why Shutterstock (SSTK) Is Down 11.5% After CEO Exit And Failed Getty Merger - And What's Next

On July 13, 2026, Shutterstock, Inc. announced that Chief Executive Officer and longtime board member Paul Hennessy stepped down, with Chief Financial Officer Rik Powell assuming the role of Interim CEO while retaining his CFO responsibilities during the transition. This leadership change comes just days after Getty Images canceled its planned merger with Shutterstock following UK regulators’ requirement that Shutterstock divest its editorial business, leaving the company to reset its...
NYSE:KBR
NYSE:KBRProfessional Services

Will NASIC’s US$866 Million IDIQ and eSAF Advisory Role Reframe KBR’s (KBR) Defense-Tech Narrative?

In July 2026, Syntholene Energy Corp. announced it hired Kellogg Brown and Root LLC as an independent consultant for a high-level technical and cost review of its hydrogen technology for eSAF deployments, paying a fixed fee without granting any securities. Around the same time, KBR’s Mission Technology Solutions unit was selected for a new five-year, multiple-award NASIC IDIQ contract with an US$866 million ceiling across all awardees, underscoring the company’s role in supporting critical...
NasdaqGS:VOR
NasdaqGS:VORBiotechs

Can Vor Biopharma’s (VOR) New Board Appointment Reshape Its Late-Stage Commercialization Strategy?

Vor Biopharma recently appointed David Zaccardelli, Pharm.D., to its Board of Directors, adding a leader who has guided multiple biopharmaceutical companies through late-stage development, regulatory approvals, commercial launches, and acquisitions, including Verona Pharma’s US$10 billion sale to Merck in 2025. His track record in advancing therapies from clinical programs to approved products and in raising over US$1 billion for development and commercialization efforts introduces...
NasdaqGS:TCBI
NasdaqGS:TCBIBanks

Texas Capital Bancshares (TCBI) Appoints Mo Jamous To Lead Its Digital Push

Texas Capital Bancshares (NasdaqGS:TCBI) has appointed Mo Jamous as Managing Director, Chief Digital and Information Officer. Jamous is set to lead the company's technological transformation, including digital banking, technology infrastructure, and AI driven solutions. He brings experience in digital banking and AI enablement from prior roles at U.S. Bank and BBVA. For Texas Capital Bancshares, a commercial and consumer banking company, this leadership change comes as digital channels and...
NYSE:FPS
NYSE:FPSElectrical

Forgent Power Solutions (FPS) Lands A Strong Buy Rating, Is It Still Below Fair Value?

Forgent Power Solutions stock in focus after Zacks recognition Forgent Power Solutions (FPS) has drawn fresh attention after being added to the Zacks Rank #1 (Strong Buy) list, alongside an upward revision to its earnings estimate for next year. This recognition, tied to an 8.7% increase in the Zacks Consensus Estimate over the past two months, comes as the stock shows strong recent momentum, including a 26.6% gain over the past 3 months. See our latest analysis for Forgent Power...
NYSE:OWL
NYSE:OWLCapital Markets

Is Blue Owl’s New Hyperscale Fiber Push Reshaping The Investment Case For Blue Owl Capital (OWL)?

Blue Owl Capital Inc. recently launched Kirkwood Infrastructure Group, a wholly owned platform that develops and operates next‑generation US communications infrastructure, integrating Florida-based South Reach Networks and building over 200 miles of new conduit and fiber across Louisiana and Mississippi. This move extends Blue Owl’s presence in digital infrastructure by directly serving hyperscale customers, data center operators, and carriers with high-capacity fiber and conduit...
NasdaqGS:ALGM
NasdaqGS:ALGMSemiconductor

How Investors Are Reacting To Allegro MicroSystems (ALGM) ASIL-D Brake-by-Wire Power Management Launch

Allegro MicroSystems recently launched the A81415, described as the industry's first ASIL-D-certified power management IC that integrates a wheel-speed sensor interface, aiming to simplify electromechanical braking and next-generation brake-by-wire designs. By combining power regulation, wheel-speed signal decoding, and support for Allegro’s XtremeSense TMR sensors in one chip, the A81415 seeks to cut component count, free up more than half of the brake-caliper board space, and trim latency...
NYSE:USB
NYSE:USBBanks

How Investors May Respond To U.S. Bancorp (USB) Earnings Beat And Push Into Small-Business Payments

U.S. Bancorp has reported its second-quarter 2026 results, with net interest income rising to US$4,361 million and net income to US$2,177 million, lifting diluted earnings per share from continuing operations to US$1.35 from US$1.11 a year earlier. Alongside these solid earnings, the bank is pushing further into small-business services with its new Enhanced Payments subscription, aiming to deepen digital relationships and broaden fee-based revenue. We’ll now examine how this earnings beat,...
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

Ligand Pharmaceuticals (LGND) Closes XOMA Deal, Is The Stock Still Below Fair Value?

Ligand Pharmaceuticals (LGND) has completed its approximately US$739 million cash acquisition of XOMA Royalty Corporation, adding seven commercial products and more than 100 development and commercial stage assets to its royalty portfolio of more than 200 assets. See our latest analysis for Ligand Pharmaceuticals. Ligand Pharmaceuticals’ latest move comes after a strong run in the stock, with the share price up 55.84% year to date and supported by a 128.54% 1 year total shareholder return...
NasdaqGS:PODD
NasdaqGS:PODDMedical Equipment

Insulet (PODD) Stock May Be Above Fair Value On Recall Lawsuit Risk

Insulet stock has fallen sharply over the past year, yet on current market multiples it still screens as expensive. This leaves investors weighing a weak share price record against valuation checks that do not flag a clear bargain. Insulet has declined 44.7% over the last 12 months, which means the stock has given back a large amount of value despite more recent short term gains. Product quality issues and related recalls around the Omnipod franchise can weigh on sentiment, while ongoing...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

Will Surging AI Demand and Licensing Growth Change Vicor's (VICR) Investment Narrative?

Vicor recently reported strong momentum in AI-focused power solutions, highlighting surging demand, a swelling backlog, expanded manufacturing capacity and higher revenue guidance ahead of its July 21 earnings release. An interesting angle for investors is Vicor’s growing mix of high-margin licensing and royalties, which complements its constrained physical capacity and enhances supply-chain flexibility. Against this backdrop of rising AI-driven demand and increased revenue guidance, we’ll...
NYSE:PSN
NYSE:PSNProfessional Services

Is Naval Lab’s US$245 Million Satellite Contract Altering The Investment Case For Parsons (PSN)?

Earlier this month, Parsons Corporation’s subsidiary Space Ground System Solutions secured a five-year, US$245 million contract from the U.S. Naval Research Laboratory to develop, sustain, and support mission-critical satellite ground systems software, extending a partnership at the Blossom Point Tracking Facility that spans more than 30 years. This award reinforces Parsons’ role in mission software for national security space programs, underscoring the company’s embedded position in...
NYSE:RLI
NYSE:RLIInsurance

How Investors May Respond To RLI (RLI) Adding Veteran Reinsurance Leader Bradshaw To Its Board

RLI Corp. recently appointed James H. Bradshaw, Chairman of Gallagher Re North America with more than 40 years of insurance industry experience, to its Board of Directors, effective July 15, 2026, with his term running until the May 2027 shareholder meeting when he will stand for re-election. By adding an independent director with deep reinsurance and underwriting expertise, RLI is signaling a focus on reinforcing risk, capital and oversight capabilities at the board level. We’ll now examine...
NasdaqGS:BKR
NasdaqGS:BKREnergy Services

Baker Hughes (BKR) Completes Chart Industries Acquisition And Reshapes Its Business Mix

Baker Hughes (NasdaqGS:BKR) has completed its acquisition of Chart Industries. The acquired operations will form a new reporting segment within Baker Hughes. The combination brings capabilities in air and gas handling, thermal management, and lifecycle services. The company is targeting significant cost synergies and has outlined leadership and financial plans to support integration. Baker Hughes is known for its role in energy technology and services, and this deal with Chart Industries...
NasdaqGS:OPRA
NasdaqGS:OPRASoftware

Did DMA-Fueled Mobile User Surge Just Shift Opera's (OPRA) Investment Narrative?

Opera reported that in the second quarter its combined monthly active users on Android and iOS browsers grew 66% in the UK and 40% in the US year over year, helped by the EU's 2024 Digital Markets Act opening up browser choice on iOS. This surge highlights how regulatory change, paired with Opera’s built-in AI, unlimited VPN and improved cross-device sync, can meaningfully shift user behavior in mature mobile markets. Against this backdrop, we’ll examine how Opera’s rapid mobile user growth,...
NYSE:M
NYSE:MMultiline Retail

Macy's (M) Names A New Bluemercury Chief, Is The Stock Fully Priced?

Macy's (M) is in focus after the company appointed luxury beauty veteran Alexandre Choueiri as CEO of its Bluemercury chain. The move gives investors fresh information on how management is thinking about the prestige beauty business. See our latest analysis for Macy's. Macy's share price is at US$23.76 after a 24.53% 90 day share price return and a 4.44% year to date share price return. The 1 year total shareholder return of 104.65% points to strong recent momentum despite a softer 30 day...
NYSE:ZIM
NYSE:ZIMShipping

Will Bullish Pre‑Earnings Sentiment Around ZIM (ZIM) Reframe Its Risk‑Reward Narrative?

In the days leading up to its upcoming earnings release, ZIM Integrated Shipping Services saw increased investor interest as analysts projected earnings per share of US$0.10 and a slight revenue decline compared with a year earlier. This attention has been underpinned by a Zacks Rank of #1 (Strong Buy), highlighting strong analyst confidence despite the softer earnings outlook. We will now look at how this strong analyst sentiment ahead of earnings could influence ZIM Integrated Shipping...
NasdaqGS:INTA
NasdaqGS:INTASoftware

Intapp (INTA) Could Be 28% Undervalued Following Its Celeste AI Launch

Intapp (INTA) has drawn fresh attention after making its Celeste expert AI coworker generally available, along with a deeper Moody’s data integration that embeds credit risk and entity screening directly into client workflows. See our latest analysis for Intapp. Intapp’s recent Celeste launch and the expanded Moody’s integration have coincided with a sharp near term rebound, with a 30 day share price return of 22.48% and a 90 day share price return of 22.53%. However, the year to date share...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

Did BRIUMVI’s Phase 2 Schizophrenia Trial Just Shift TG Therapeutics' (TGTX) Investment Narrative?

In early July 2026, TG Therapeutics began an open-label, Phase 2 trial of BRIUMVI (ublituximab-xiiy) in about 60 adults with treatment-resistant schizophrenia, who will continue standard antipsychotic therapy while receiving intravenous BRIUMVI. This move extends BRIUMVI’s use beyond relapsing multiple sclerosis into a difficult-to-treat psychiatric indication, potentially broadening TG Therapeutics’ future therapeutic footprint if safety and efficacy are confirmed. We’ll now examine how...
NYSE:MKL
NYSE:MKLInsurance

Markel (MKL) Appoints Marc Copland To Lead Property Growth In Canada

Markel Insurance, part of Markel Group (NYSE:MKL), appointed Marc Copland as Vice President, Product Line Leader, Property in Canada. Copland will focus on expanding Markel Canada's Property portfolio and using technology to support product development. The role is intended to reinforce Markel Canada's position in the specialty insurance market. For shareholders watching how Markel Group positions its insurance operations, this appointment highlights attention on the Canadian Property...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

BWX Technologies (BWXT) Stock Looks Fully Valued With Cash Flow And Earnings Both Rich

BWX Technologies has delivered a strong 223.9% return over the past 5 years. At a recent share price of US$176.91, both the intrinsic value estimate from a Discounted Cash Flow (DCF) approach and earnings based multiples currently point to the stock trading at a premium. A 223.9% gain over 5 years highlights how much optimism is already reflected in BWX Technologies' share price. Expectations that BWX Technologies can keep converting its project pipeline into reliable cash flows may support...
NYSE:WSM
NYSE:WSMSpecialty Retail

Williams-Sonoma (WSM) Following Pink Palm Puff Launch Looks Fully Valued Against Fair Value

Williams-Sonoma (WSM) is drawing fresh attention after Pottery Barn Teen unveiled a collaboration with Pink Palm Puff, introducing coastal and surf inspired designs across teen rooms and back to school essentials. See our latest analysis for Williams-Sonoma. That launch comes as Williams-Sonoma shares trade at US$222.84, with a 90-day share price return of 16.37% and a year-to-date share price return of 18.63%. The 1-year total shareholder return sits at 37.02%, and the 3-year total...
NYSE:CAT
NYSE:CATMachinery

Caterpillar (CAT) Stock Still Looks Pricey On Its 372% Run

Caterpillar stock has delivered a very strong 372.0% total return over the past 5 years, yet the valuation checks are pulling in different directions, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples still screen more supportive. A roughly 372.0% gain over 5 years puts Caterpillar in the category of very strong long term performers, which can leave less room for further upside if expectations are already high. On the one hand,...